Tilray Inc (NASDAQ:TLRY) Shares Sold by BNP Paribas Financial Markets

BNP Paribas Financial Markets decreased its stake in shares of Tilray Inc (NASDAQ:TLRY - Free Report) by 97.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 41,066 shares of the company's stock after selling 1,778,428 shares during the period. BNP Paribas Financial Markets' holdings in Tilray were worth $55,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Lido Advisors LLC purchased a new position in Tilray during the fourth quarter worth $28,000. Verdence Capital Advisors LLC purchased a new position in Tilray during the fourth quarter worth $29,000. Dudley Capital Management LLC purchased a new position in Tilray during the fourth quarter worth $29,000. Newman Dignan & Sheerar Inc. increased its position in Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock worth $35,000 after buying an additional 10,000 shares in the last quarter. Finally, Brooklyn FI LLC purchased a new position in Tilray during the fourth quarter worth $36,000. Hedge funds and other institutional investors own 9.35% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Piper Sandler decreased their price objective on Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a report on Wednesday, April 9th. Roth Capital restated a "neutral" rating on shares of Tilray in a report on Monday, April 14th.

Tilray Trading Up 4.5%

Shares of TLRY stock traded up $0.02 during mid-day trading on Friday, hitting $0.41. 28,643,940 shares of the company's stock were exchanged, compared to its average volume of 28,837,860. Tilray Inc has a fifty-two week low of $0.37 and a fifty-two week high of $2.15. The stock has a market cap of $408.23 million, a price-to-earnings ratio of -1.35 and a beta of 1.95. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. The stock has a 50-day simple moving average of $0.47 and a two-hundred day simple moving average of $0.85.

Tilray (NASDAQ:TLRY - Get Free Report) last issued its earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. Equities analysts expect that Tilray Inc will post -0.2 EPS for the current fiscal year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.